Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ezgi Oymak
Observed names:
E. Oymak,
EZGI OYMAK,
Ezgi OYMAK,
Ezgi oymak,
Oymak, Ezgi,
ezgi oymak,
oymak, ezgi
show all 7
Observed institutions:
Sakarya University,
Başkent University,
Sakarya Eğitim ve Araştırma Hastanesi,
Özel İskenderun Gelişim Hastanesi,
Cukurova University
ORCID:
0000-0001-6646-0868
Observed ORCID:
0000-0001-6646-0868
OpenAlex ID:
A5058361870
Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide
2011
·
Erkan Topkan
, Savaş Topuk
, et al.
·
American Journal of Clinical Oncology
·
59
Prognostic Value of Pretreatment 18F-fluorodeoxyglucose Uptake in Patients With Cervical Cancer Treated With Definitive Chemoradiotherapy
2013
·
Cem Onal
, Mehmet Reyhan
, et al.
·
International Journal of Gynecological Cancer
·
56
Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses
2009
·
Cem Onal
, Gungor Arslan
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
50
PDF
Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)
2020
·
Pervin Hurmuz
, Cem Onal
, et al.
·
Strahlentherapie und Onkologie
·
42
Dosimetric comparison of the field-in-field technique and tangential wedged beams for breast irradiation
2011
·
Cem Onal
, Aydan Sonmez
, et al.
·
Japanese Journal of Radiology
·
40
Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients
2021
·
Cem Onal
, Gokhan Ozyigit
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
38
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment
2021
·
Cem Onal
, Fatih Kose
, et al.
·
The Prostate
·
29
Evaluation of Field-in-Field Technique for Total Body Irradiation
2012
·
Cem Onal
, Aydan Sonmez
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
27
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients
2020
·
Cem Onal
, Gokhan Ozyigit
, et al.
·
Radiotherapy and Oncology
·
25
Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis
2020
·
Cem Onal
, Melis Gultekin
, et al.
·
International Journal of Gynecological Cancer
·
24
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT
2021
·
Cem Onal
, Gokhan Ozyigit
, et al.
·
Clinical Nuclear Medicine
·
23
Isolated Mediastinal Lymph Node False Positivity of [18F]-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography in Patients With Cervical Cancer
2013
·
Cem Onal
, Ezgi Oymak
, et al.
·
International Journal of Gynecological Cancer
·
21
Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients
2023
·
Cem Onal
, Gurcan Erbay
, et al.
·
The Prostate
·
20
The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy
2022
·
Cem Onal
, Gurcan Erbay
, et al.
·
Radiotherapy and Oncology
·
19
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
2022
·
Cem Onal
, Ozan Cem Guler
, et al.
·
Strahlentherapie und Onkologie
·
15
Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy
2020
·
Cem Onal
, Nese Torun
, et al.
·
Annals of Nuclear Medicine
·
15
The Hematologic Parameters in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
2019
·
Cem Onal
, Ali Murat Sedef
, et al.
·
Future Oncology
·
13
Correlation of Conventional and Conformal Plan Parameters for Predicting Radiation Pneumonitis in Patients Treated with Breast Cancer
2012
·
Cem Onal
, Ezgi Oymak
, et al.
·
Journal of Breast Cancer
·
13
PDF
Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes
2022
·
Sezin Yuce Sari
, Ozan Cem Guler
, et al.
·
Journal of obstetrics and gynaecology research
·
12
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
2022
·
Cem Onal
, Pervin Hurmuz
, et al.
·
Clinical & Translational Oncology
·
12
Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy
2021
·
Cem Onal
, Sezin Yuce Sari
, et al.
·
Acta Oncologica
·
12
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
2022
·
Cem Onal
, Ezgi Oymak
, et al.
·
Strahlentherapie und Onkologie
·
11
Clinical parameters and nomograms for predicting lymph node metastasis detected with 68Ga‐PSMA‐PET/CT in prostate cancer patients candidate to definitive radiotherapy
2021
·
Cem Onal
, Gokhan Ozyigit
, et al.
·
The Prostate
·
11
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
2019
·
Berna Akkus Yildirim
, Cem Onal
, et al.
·
Strahlentherapie und Onkologie
·
11
Bilateral Choroidal Metastases from Lung Adenocarcinoma: A Case Report
2016
·
Hasan Ergenc
, Attila Onmez
, et al.
·
Case Reports in Oncology
·
11
PDF
Show more works
View as search
Works count:
80
Citation count:
703
H-index:
15
I10-index:
26
Year
Topic
Type
